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The evaluation of children presenting with urinary tract infection (UTI) has long entailed sonography and cystography to identify
all urological abnormalities that might contribute to morbidity. The identiﬁcation of vesicoureteral reﬂux (VUR) has been of
primary concern since retrospective studies from the 1930s to 1960s established a strong association between VUR, recurrent UTI,
and renal cortical scarring. It has been proposed that all VUR carries a risk for renal scarring and, therefore, all VUR should be
identiﬁed and treated. We will not discuss the controversies surrounding VUR treatment in this review focusing instead on a new
paradigmfortheevaluationofthechildwithUTIthatispredicatedonidentifyingthoseatriskforscarringwhoaremostdeserving
of further evaluation by cystography.
Copyright © 2009 H. G. Pohl and A. B. Belman. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Concern for the inﬂuence of vesicoureteral reﬂux (VUR) on
renal cortical scarring began with the recognition that VUR
transmitsbacteriatotheupperurinarytractandtheobserva-
tion that APN, VUR, and renal scarring frequently coexisted
in the same patient. Although APN was considered to be an
ascending infection, it was mistakenly considered to always
result from VUR [1, 2]. With these relationships established,
the American Academy of Pediatrics Subcommittee on
Urinary Tract Infection published a practice parameter that
recommends renal-bladder sonography (RBUS) and voiding
cystourethrography (VCUG) for the evaluation of urinary
tract infection in febrile infants and young children [3].
Sonography is appealing as a method of evaluation fol-
lowing UTI; however, its ability to detect upper urinary tract
abnormalities is limited. Although RBUS is noninvasive and
suﬃciently sensitive to evaluate collecting system dilatation,
controlled trials have found it to be less sensitive than
contrast cystography and 99m-Tc-dimercaptosuccinic acid
(DMSA) renal scintigraphy in detecting VUR or parenchy-
mal lesions. As much as 60% of reﬂux and 50% of renal
scan abnormalities noted on DMSA are routinely missed by
sonography [4–6]. Given the prevalence of prenatal sonog-
raphy, few RBUSs performed for the evaluation of febrile
UTI demonstrate clinically signiﬁcant abnormalities [7].
Alternatively, VCUG is the gold standard for the detection
of VUR; however, it is invasive, requiring catheterization,
generally of the nonsedated child. Despite the liabilities
of this evaluation paradigm, it remains the recommended
guideline, although there is a tendency for children not to
undergo recommended testing, particularly when treated as
outpatients for their UTI [8]. These limitations combined
with an increasing clinical experience with DMSA renal
scans has led some to advocate a novel paradigm for the
evaluation of children with UTI, termed the “top-down
approach” which focuses on identifying children at risk for
renal scarring, whether or not VUR is present, as compared
withtherecommendedschemewhichproposestoidentifyall
VUR. Both approaches employ ionizing radiation to image
the urinary tract, but a direct comparison of eﬀective doses
cannot be made reliably because the radiation is focused in
the one case (cystography)anddiﬀusedthroughoutthebody
in the other (DMSA renal scan). Gonadal dosimetry is lower
for continuous ﬂuoroscopic cystography (eﬀective dose,
0.45mSv) as compared with DMSA renal scans (eﬀective2 Advances in Urology
dose, 1.8mSV; ovary, 85mrads; testis 45mrads) but as we
will demonstrate, the “top-down” approach oﬀers signiﬁcant
advantages that outweigh this potential liability.
2. Renal Scintigraphy in the Evaluationof
UTI, VUR,andAcquired
R e n alC o rtic alA b n o rm al itie s
Experimental studies in the reﬂuxing piglet model of
ascending acute pyelonephritis were conducted using strict
histopathologic criteria as the standard of reference to
evaluate the true sensitivity and speciﬁcity of renal cor-
tical scintigraphy [9, 10]. These experimental studies, as
well as clinical observations, have facilitated our ability to
discriminate between lesions consistent with acute inﬂam-
mation and those that represent congenital or acquired
abnormalities of the renal cortex. Acute inﬂammation results
in relative photopenia of the renal cortex without loss of
the renal contour. Over time, inﬂammation can lead to
scarring of the renal cortex that produces loss of volume
as renal tissue contracts. This volume loss is represented
as disruption of the renal contour with photopenia. Reno-
graphically, congenital abnormalities of the renal cortex can
look similar to those that are acquired following infection,
the ability to distinguish between the two depends on
whether the child had no UTI prior to the abnormality
being discovered (congenital) or whether a DMSA scan
previously demonstrated no cortical lesion or only those
consistent with inﬂammation (acquired). In the absence of
acuteinﬂammation,thepresenceofcongenitalabnormalities
of the renal cortex, such as hypoplasia or volume loss,
suggests VUR and warrants cystography. Identiﬁcation of
developmental renal parenchymal abnormalities is most
accurately made in the newborn in whom one knows UTI
did not play a role. Beyond that, it may be diﬃcult to dif-
ferentiate acquired from congenital defects regardless of UTI
history.
The DMSA scan was determined to be highly sensitive
and reliable for the detection and localization of exper-
imental acute pyelonephritis, with a sensitivity of 87 to
89 percent and speciﬁcity of 100 percent for both. When
individual pyelonephritic lesions were analyzed, DMSA scan
ﬁndings correlated with histopathological changes with an
overall agreement rate of 89 to 94 percent. Those lesions not
detected were microscopic foci of inﬂammation not evident
on gross examination and not associated with signiﬁcant
parenchymal damage. DMSA nuclear renography has been
shown to be the most accurate (96%) for the detection of
APN as compared with gadolinium-enhanced MRI (91%),
contrast CT scan (90%), and power Doppler sonography
(69%) [11].
The clinical diagnosis of acute pyelonephritis tradition-
ally has been made on the basis of the classic signs and
symptoms of fever and ﬂank pain or tenderness associated
with pyuria and positive urine culture. However, accurate
diagnosis based solely on these parameters is often incorrect,
particularly in neonates and infants [12]. Despite the fact
that the majority of patients (50 to 80 percent) with
fever and systemic clinical ﬁndings consistent with acute
pyelonephritis have abnormal DMSA scan ﬁndings, there
is still a high false-positive and/or negative rate based on
routine clinical and laboratory parameters, including fever,
elevated WBC, elevated c-reactive protein (CRP), elevated
erythrocyte sedimentation rate (ESR), and the presence of
VUR [13]. Not only is DMSA scintigraphy highly sensitive
and speciﬁc for the diagnosis of acute pyelonephritis, but
it also provides important information regarding renal
function and the extent of renal parenchymal inﬂammation.
Documentation of renal parenchymal damage associated
with acute pyelonephritis is fundamental to understanding
the roles of infection and vesicoureteral reﬂux in the etiology
of pyelonephritis and renal scarring.
The critical role that infection plays in the pathogenesis
of renal scarring associated with VUR was clariﬁed by
Ransley and Risdon’s experimental studies on the reﬂuxing
piglet model, by which—in the face of VUR and normal
voiding pressures—they showed that renal scarring occurs
only when UTI is present [14]. While a single episode of
APN can lead to signiﬁcant renal damage, a clear association
between the number of APN attacks and the incidence of
renal scarring has been reported [15–19]. Renal scarring can
be prevented or diminished, whether or not APN occurred
in the face of VUR, by the appropriate administration of
antibiotics [15, 20–22]. Based on all of the above, it is clear
that infection, not reﬂux alone, is a prerequisite for acquired
renal scarring.
3. Evolution of Acute Inﬂammation to
Postinfection Scars
Several investigators have now evaluated the evolution of the
acute inﬂammatory changes associated with pyelonephritis
using serial DMSA renal scans [23–27]. Acute DMSA renal
scan defects persisted as renal scars in 36 to 52 percent
of kidneys. The sites of new renal scarring corresponded
exactly to those sites of acute pyelonephritis seen on the
initial DMSA renal scans, conﬁrming the primary role of
the acute inﬂammatory response to infection in the etiology
of acquired renal scarring. Contralateral normal kidneys
and initially uninvolved areas of abnormal kidneys have
almost always remained normal on follow-up DMSA renal
scans.Surprisingly, reﬂux has been identiﬁed in only 25 to
50 percent of kidneys that developed new renal scarring.
This is attributable in part to the fact that the majority
of patients (63 to 75 percent) with acute inﬂammatory
changes on the initial DMSA renal scans did not have
VUR. In one prospective study of 38 kidneys with initially
abnormal DMSA scans, scarring developed in 6 of 15 (40
percent) kidneys with associated VUR and in 10 of 23 (42
percent) kidneys without demonstrable reﬂux [25]. Others
have observed similar ﬁndings [28]. These observations
provide convincing clinical evidence that renal parenchymal
infection,ratherthanvesicoureteralreﬂux,istheprerequisite
for acquired (postnatal) renal scarring and that the incidence
of VUR in children with acute pyelonephritis is lower than
commonly appreciated.
Despite these ﬁndings, the importance of VUR (particu-
larly grades III or higher) as a risk factor for renal scarringAdvances in Urology 3
Table 1
CPT code Charge Total charge
U/S, renal bladder 76770
∗ $651 $832
76770.26
∗ $181
VCUG 74455 $779 $852
74455.26 $73
DMSA 78700 $781 $968
78700.26 $187
Assumptions used in calculations:
Positive DMSA renal scans among children with febrile UTI 50–80%
Presence of VUR among children with febrile UTI 25–50%
Presence of VUR among children with positive DMSA scan 66%
Charge per case of VUR diagnosed
Bottom-up $3368–$8420
Top-down $2630–$3033
∗The ﬁrst CPT code and charge relates to the technical fee for performing the examination, while the second code (.26 modiﬁed) relates to the professional
component.
should not be discounted. Clearly, patients with moderate
and severe reﬂux are much more likely to develop acute
pyelonephritic damage than children with mild or no reﬂux
[12, 29]. Furthermore, although 62 percent of the kidneys
with postpyelonephritic renal scarring in one study were
drained by nonreﬂuxing ureters, renal scarring was still
signiﬁcantly more common in those kidneys with grade III
or higher VUR compared with kidneys with mild or no
reﬂux [29]. Thus, the increased propensity for scarring in
patients with higher grades of VUR is attributable in part to
the increased risk of these kidneys for acute inﬂammatory
damage at the time of the initial infection [12, 28, 30].
4.The“Top-Down” Approach
The DMSA renal scan could supplant the standard evalua-
tion scheme since it can better discriminate which child is at
risk for renal scarring irrespective of the presence of VUR. In
this novel algorithm, a child who presents with clinical signs
and symptoms suggestive of pyelonephritis ﬁrst undergoes
a DMSA renal scan to detect renal inﬂammation. Once
radiographic evidence of renal involvement is demonstrated,
thechildthenundergoescystographytosearchforVUR.This
approach is supported by the following two studies.
Hansson et al. retrospectively reviewed 303 children
under 2 years of age who presented with a ﬁrst UTI (82%
of whom had fever on presentation) [31]. VUR was found in
26% of the children (80/303), 66% of whom had abnormal
DMSA scans, while no abnormalities were detected in the
remaining 27 patients. An approach based on identifying
renal cortical abnormalities prior to obtaining a VCUG
would have identiﬁed not only the 66% of children with
VUR presumably at risk for further scarring, but it would
also have identiﬁed the 46% of the children without VUR
who were also at renal risk, and most importantly, it
would have excluded 120 children (40%) without VUR from
a VCUG. One obvious criticism might be this approach
inability to detect 34% (27/80) of VUR without renal
involvement.However,74%ofthesewerelowgradewhilethe
remainingsevencasesofVUR—allgradeIII—eitherresolved
orimprovedsigniﬁcantlyduringatwo-yearperiodfollow-up
period with no episodes of recurrent UTI and no new renal
scars documented.
In a follow-up study, Preda et al. prospectively evaluated
290 children less than 1 year of age with UTI (79% of whom
had fever on presentation) with VCUG and DMSA renal
scans [32]. Fifty-one percent of the patients had positive
scans, including 85% (44/52) of the children later found to
haveVUR.AmongtheeightcasesofVURthatwere“missed”
by DMSA scans, 7 were of low grade, the remaining boy
has grade III VUR with no acquired renal scars in follow-up
despite an episode of breakthrough UTI.
This algorithm is further supported by the observations
that while clinically signiﬁcant acute lesions may occur in
the presence or absence of VUR, signiﬁcant renal scarring is
most likely to occur in those with grades III and IV VUR
[33]. Taken together, these studies suggest that the “top-
down approach” is able to identify all children at risk for
upper tract damage following UTI, whether or not they have
VUR, and excludes children who may not be at risk, again
irrespective of the presence of VUR. The sensitivity of this
approachisimprovedbyperformingtheDMSArenalscanas
close to the time of the febrile UTI as possible. In the absence
of acute inﬂammatory changes, the presence of congenital
abnormalities of the renal cortex such as hypoplasia or focal
volume loss typical of scarring is highly suggestive of VUR
and warrants cystography.
5.CostSavingsofthe“Top-Down” Approach
The “top-down” approach also serves to reduce the overall
charges for the evaluation of children with UTIs. How
great a reduction depends on what estimates are used
for the prevalence of patients with VUR among children
with febrile UTI, and among those with positive DMSA
renal scans as well as the timing of evaluation. DMSA
scans performed at a longer interval following the acute
episode are less likely to demonstrate pyelonephritis, as4 Advances in Urology
many as half of those lesions having resolved. In Table 1,
we present charge data for Children’s National Medical
Center and the assumptions used to calculate the cost per
diagnosis of VUR by the traditional “bottom-up” approach
($3368–$8420) versus the “top-down” approach ($2630–
$3033). This should not be surprising since almost half
of the charge associated with the standard “bottom-up”
approach is associated with sonography, a study that rarely
identiﬁes signiﬁcant abnormalities in children with UTIs in
contemporary series. If one routinely obtains DMSA renal
scans on children with moderate to severe VUR, then the
cost of this additional examination would further increase
the charges associated with the bottom up approach in up to
25% of the children with VUR.
6. Recommendations
In our eﬀort to identify those children who are most at risk,
we might be tempted to apply certain demographic facts to
further minimize studies. Patient age is recognized as being a
riskfactorforrenalscarring;youngerindividualsarethought
to be more susceptible. Gender may also play a role as
younger males, particularly those who are not circumcised,
tend to be at greater risk for UTI as well as high grade
reﬂux. Reﬂux in blacks is also less common; however the
renaleﬀectsarethesameasinothergroupsinthosewhohave
reﬂux [34]. Finally, older children may be less susceptible to
renal scarring following pyelonephritis.
Therefore, a negative evaluation by any means, whether
by the traditional approach or by the “top-down” approach,
may not be suﬃcient to exclude all children at risk.
Therefore, those who present with recurrent febrile UTI
deserve further attention. We, therefore, recommend that
a prudent approach includes DMSA renal scans for all
childrenwithfebrileUTI,ideallyasclosetotheacuteepisode
as possible. Those with positive scans should undergo
cystography. If VUR is identiﬁed, the clinician should
then formulate an appropriate treatment plan depending
on various factors such as likelihood of VUR resolution,
likelihood of renal scarring, taking into consideration
parental concerns regarding various treatments, and their
outcomes. Children with a negative DMSA scan require no
further evaluation unless recurrent febrile UTI occurs, in
which case cystography should be performed. The use of
antimicrobial prophylaxis should be recommended based
on known risks for recurrent UTI and for renal scarring
should UTI occur regardless of the presence of absence of
reﬂux.
7. Summary
The “top-down” evaluation provides an assessment of risk
for renal scarring that strongly correlates with the presence
of clinically relevant VUR. In addition to being a more cost-
eﬀective means of evaluating children with febrile UTIs, it
is also predicted to lessen medical care costs by reducing the
number of children on antibiotic prophylaxis and of children
undergoing surgery for reﬂux that is unlikely to result in
renal scarring.
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